Ramsay Générale de Santé SA (EPA:GDS)
France · Delayed Price · Currency is EUR 11.05
+0.40 (3.76%)
Aug 21, 2026, 4:53 PM CET
Ramsay Générale de Santé Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 5,360 | 5,242 | 5,007 | 4,702 | 4,301 | 4,023 | |
Revenue Growth | 3.71% | 4.70% | 6.49% | 9.31% | 6.92% | 7.38% |
Cost of Revenue | 3,886 | 3,814 | 3,635 | 3,478 | 3,135 | 2,934 |
Gross Profit | 1,474 | 1,428 | 1,372 | 1,224 | 1,166 | 1,088 |
Selling, General & Admin | 83.3 | 85.7 | 80.3 | 86.2 | 84.6 | 85.9 |
Other Operating Expenses | 748.4 | 719.2 | 678.9 | 492.4 | 333.4 | 358.6 |
Operating Expenses | 1,267 | 1,239 | 1,186 | 981.8 | 795.3 | 816.3 |
Operating Income | 207.6 | 189.1 | 185.9 | 242.1 | 370.9 | 272 |
Interest Expense | -181.7 | -199.1 | -177 | -156.4 | -124.1 | -135.4 |
Interest & Investment Income | 5.7 | 6.3 | 3.3 | 10.4 | 1.2 | 1.4 |
Earnings From Equity Investments | - | - | - | - | -0.1 | - |
Other Non Operating Income (Expenses) | -13.4 | -15.5 | -29.4 | -6.7 | 16.8 | -13.3 |
EBT Excluding Unusual Items | 18.2 | -19.2 | -17.2 | 89.4 | 264.7 | 124.7 |
Merger & Restructuring Charges | -9.2 | -9.2 | -12.8 | -12.6 | 3.5 | -11.3 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 3.5 |
Gain (Loss) on Sale of Assets | - | - | - | 35.5 | 7.5 | -0.2 |
Asset Writedown | -2.2 | -2.2 | -23.3 | - | -0.8 | -13.4 |
Other Unusual Items | -1 | -2.8 | 12.5 | -24.6 | -89.8 | - |
Pretax Income | 5.8 | -33.4 | -40.8 | 87.7 | 185.1 | 103.3 |
Income Tax Expense | 13.5 | 1.6 | -4.1 | 23.8 | 57.3 | 29.5 |
Earnings From Continuing Operations | -7.7 | -35 | -36.7 | 63.9 | 127.8 | 73.8 |
Earnings From Discontinued Operations | -5.4 | -3.1 | - | - | - | - |
Net Income to Company | -13.1 | -38.1 | -36.7 | 63.9 | 127.8 | 73.8 |
Minority Interest in Earnings | -14.7 | -16 | -17.2 | -14.5 | -9.4 | -8.8 |
Net Income | -27.8 | -54.1 | -53.9 | 49.4 | 118.4 | 65 |
Net Income to Common | -27.8 | -54.1 | -53.9 | 49.4 | 118.4 | 65 |
Net Income Growth | - | - | - | -58.28% | 82.15% | 385.07% |
Shares Outstanding (Basic) | 111 | 110 | 110 | 110 | 110 | 110 |
Shares Outstanding (Diluted) | 111 | 110 | 110 | 110 | 110 | 110 |
Shares Change | -0.80% | 0.00% | 0.00% | -0.01% | 0.01% | - |
EPS (Basic) | -0.25 | -0.49 | -0.49 | 0.45 | 1.07 | 0.59 |
EPS (Diluted) | -0.25 | -0.49 | -0.49 | 0.45 | 1.07 | 0.59 |
EPS Growth | - | - | - | -58.17% | 81.68% | 390.80% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 570 | 550.9 | 418.3 | 426.7 | 68.9 | 475.9 |
Free Cash Flow Per Share | 5.13 | 4.99 | 3.79 | 3.87 | 0.62 | 4.31 |
Gross Margin | 27.50% | 27.24% | 27.40% | 26.03% | 27.12% | 27.05% |
Operating Margin | 3.87% | 3.61% | 3.71% | 5.15% | 8.62% | 6.76% |
Profit Margin | -0.52% | -1.03% | -1.08% | 1.05% | 2.75% | 1.62% |
Free Cash Flow Margin | 10.63% | 10.51% | 8.36% | 9.08% | 1.60% | 11.83% |
EBITDA | 371.7 | 353.3 | 366.6 | 414.3 | 533.3 | 643.8 |
EBITDA Margin | 6.93% | 6.74% | 7.32% | 8.81% | 12.40% | 16.00% |
D&A For EBITDA | 164.1 | 164.2 | 180.7 | 172.2 | 162.4 | 371.8 |
EBIT | 207.6 | 189.1 | 185.9 | 242.1 | 370.9 | 272 |
EBIT Margin | 3.87% | 3.61% | 3.71% | 5.15% | 8.62% | 6.76% |
Effective Tax Rate | 232.76% | - | - | 27.14% | 30.96% | 28.56% |